antalarmin has been researched along with ondansetron in 1 studies
| Studies (antalarmin) | Trials (antalarmin) | Recent Studies (post-2010) (antalarmin) | Studies (ondansetron) | Trials (ondansetron) | Recent Studies (post-2010) (ondansetron) |
|---|---|---|---|---|---|
| 181 | 0 | 76 | 3,380 | 1,216 | 994 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amano, T; Ariga, H; Ishida, T; Kimura, T; Matsueda, K; Tajiri, H; Torii, A; Uehara, H; Yamato, S | 1 |
1 other study(ies) available for antalarmin and ondansetron
| Article | Year |
|---|---|
Urocortin I is present in the enteric nervous system and exerts an excitatory effect via cholinergic and serotonergic pathways in the rat colon.
Topics: Animals; Atropine; Colon; Corticotropin-Releasing Hormone; Dioxanes; Electric Stimulation; Enteric Nervous System; Gastrointestinal Motility; Hexamethonium; Immunohistochemistry; Male; NG-Nitroarginine Methyl Ester; Ondansetron; Peptide Fragments; Piperidines; Pyrimidines; Pyrroles; Rats; Receptors, Corticotropin-Releasing Hormone; Serotonin 5-HT3 Receptor Antagonists; Serotonin 5-HT4 Receptor Antagonists; Tetrodotoxin; Urocortins | 2007 |